![](https://monteverdelaw.com/wp-content/uploads/case-logo/cellular-biomedicine-group-inc-0.jpg)
Cellular Biomedicine Group, Inc. (CBMG) related to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. Under the terms of the agreement, CBMG shareholders will receive $19.75 in cash for each share of CBMG stock they own.